Skip to main content

Advertisement

SpringerLink
Log in

Kinetics of Marked Development of Lung Metastasis of Rat Prostatic Carcinomas Transplanted in Syngeneic Rats

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

In order to investigate how and when metastases develop under experimental conditions, kinetics of the size and the number of lung metastasis lesions in F344 rats were examined after syngeneic transplantation of rat prostate carcinomas induced by 3,2′-dimethyl-4-aminobiphenyl (DMAB). Cell proliferation of the subcutaneous tumor and lung metastatic lesions was evaluated along with the expression of VEGF-A splicing variants and endostatin, serum VEGF levels and vascular density in the tumor. Several pieces of tumor tissue were introduced subcutaneously into two different sites on the dorsal side of F344 rats through a 14G needle. Average body weight of recipient rats markedly decreased despite only a gradual increase in tumor volume. The absolute total number of metastatic lesions in rats (n=5) were 2, 10, 19 and 194 at weeks 7.5, 9, 11 and 13, respectively, and a notable increase was observed at week 13. Similarly, the mitotic index of lung metastatic lesions increased remarkably at week 9 while the mitotic index and apoptotic index of transplanted tumors did not change throughout the experimental period. Expression of VEGF-A121, A164, A188 and endostatin, serum VEGF levels and vascular density did not correlate with the spread of lung lesions. In conclusion, both the number and the size of metastatic lesions increased at the same time after a notable increase in cell proliferation. Factors other than VEGF or endostatin may be involved in the mechanism of explosive lung metastasis spread.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A Jemal RC Tiwari T Murray et al. (2004) ArticleTitleCancer statistics, 2004 CA Cancer J Clin 54 IssueID1 8–29 Occurrence Handle14974761

    PubMed  Google Scholar 

  2. CJ Dimitroff A Sharma RJ Bernacki (1998) ArticleTitleCancer metastasis: A search for therapeutic inhibition Cancer Invest 16 IssueID4 279–90 Occurrence Handle9589037

    PubMed  Google Scholar 

  3. EC Kohn (1993) ArticleTitleDevelopment and prevention of metastasis Anticancer Res. 13 IssueID6B 2553–9 Occurrence Handle7510940

    PubMed  Google Scholar 

  4. F Rastinejad PJ Polverini NP Bouck (1989) ArticleTitleRegulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene Cell 56 IssueID3 345–55 Occurrence Handle10.1016/0092-8674(89)90238-9 Occurrence Handle2464438

    Article  PubMed  Google Scholar 

  5. S Parangi M O’Reilly G Christofori et al. (1996) ArticleTitleAntiangiogenic therapy of transgenic mice impairs de novo tumor growth Proc Natl Acad Sci USA 93 IssueID5 2002–7 Occurrence Handle10.1073/pnas.93.5.2002 Occurrence Handle8700875

    Article  PubMed  Google Scholar 

  6. DJ Good PJ Polverini F Rastinejad et al. (1990) ArticleTitleA tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin Proc Natl Acad Sci USA 87 IssueID17 6624–8 Occurrence Handle1697685

    PubMed  Google Scholar 

  7. MS O’Reilly L Holmgren Y Shing et al. (1994) ArticleTitleAngiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 IssueID2 315–28 Occurrence Handle10.1016/0092-8674(94)90200-3 Occurrence Handle7525077

    Article  PubMed  Google Scholar 

  8. C Chen S Parangi MJ Tolentino et al. (1995) ArticleTitleA strategy to discover circulating angiogenesis inhibitors generated by human tumors Cancer Res 55 IssueID19 4230–3 Occurrence Handle7545537

    PubMed  Google Scholar 

  9. MS O’Reilly T Boehm Y Shing et al. (1997) ArticleTitleEndostatin: An endogenous inhibitor of angiogenesis and tumor growth Cell 88 IssueID2 277–85 Occurrence Handle9008168

    PubMed  Google Scholar 

  10. J Folkman (2002) ArticleTitleRole of angiogenesis in tumor growth and metastasis Semin Oncol 29 15–8 Occurrence Handle10.1053/sonc.2002.37263

    Article  Google Scholar 

  11. M Asamoto N Hokaiwado YM Cho et al. (2001) ArticleTitleProstate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent Cancer Res 61 IssueID12 4693–700 Occurrence Handle11406539

    PubMed  Google Scholar 

  12. JR Gingrich RJ Barrios RA Morton et al. (1996) ArticleTitleMetastatic prostate cancer in a transgenic mouse Cancer Res 56 IssueID18 4096–102 Occurrence Handle8797572

    PubMed  Google Scholar 

  13. JR Gingrich NM Greenberg (1996) ArticleTitleA transgenic mouse prostate cancer model Toxicol Pathol 24 IssueID4 502–4 Occurrence Handle8864193

    PubMed  Google Scholar 

  14. J Folkman (1996) ArticleTitleTumor angiogenesis and tissue factor Nat Med 2 IssueID2 167–8 Occurrence Handle10.1038/nm0296-167 Occurrence Handle8574960

    Article  PubMed  Google Scholar 

  15. A Hori R Sasada E Matsutani et al. (1991) ArticleTitleSuppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor Cancer Res 51 IssueID22 6180–4 Occurrence Handle1718597

    PubMed  Google Scholar 

  16. KJ Kim B Li J Winer et al. (1993) ArticleTitleInhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 362 IssueID6423 841–4 Occurrence Handle10.1038/362841a0 Occurrence Handle7683111

    Article  PubMed  Google Scholar 

  17. B Millauer LK Shawver KH Plate et al. (1994) ArticleTitleGlioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 367 IssueID6463 576–9 Occurrence Handle10.1038/367576a0 Occurrence Handle8107827

    Article  PubMed  Google Scholar 

  18. KA Houck N Ferrara J Winer et al. (1991) ArticleTitleThe vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA Mol Endocrinol 5 IssueID12 1806–14 Occurrence Handle1791831

    PubMed  Google Scholar 

  19. DW Leung G Cachianes WJ Kuang et al. (1989) ArticleTitleVascular endothelial growth factor is a secreted angiogenic mitogen Science 246 IssueID4935 1306–9 Occurrence Handle2479986

    PubMed  Google Scholar 

  20. Z Poltorak T Cohen R Sivan et al. (1997) ArticleTitleVEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix J Biol Chem 272 IssueID11 7151–8 Occurrence Handle10.1074/jbc.272.11.7151 Occurrence Handle9054410

    Article  PubMed  Google Scholar 

  21. E Tischer R Mitchell T Hartman et al. (1991) ArticleTitleThe human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing J Biol Chem 266 IssueID18 11947–54 Occurrence Handle1711045

    PubMed  Google Scholar 

  22. G Bunone P Vigneri L Mariani et al. (1999) ArticleTitleExpression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features Am J Pathol 155 IssueID6 1967–76 Occurrence Handle10595926

    PubMed  Google Scholar 

  23. J Folkman (1992) ArticleTitleThe role of angiogenesis in tumor growth Semin Cancer Biol 3 IssueID2 65–71 Occurrence Handle1378311

    PubMed  Google Scholar 

  24. RS Herbst M Hidalgo AS Pierson et al. (2002) ArticleTitleAngiogenesis inhibitors in clinical development for lung cancer Semin Oncol 29 IssueID1 Suppl 4 66–77 Occurrence Handle10.1053/sonc.2002.31527 Occurrence Handle11894016

    Article  PubMed  Google Scholar 

  25. K Hata R Fujiwaki K Nakayama et al. (2001) ArticleTitleExpression of the Endostatin gene in epithelial ovarian cancer Clin Cancer Res 7 IssueID8 2405–9 Occurrence Handle11489819

    PubMed  Google Scholar 

  26. YP Chau SY Lin JH Chen et al. (2003) ArticleTitleEndostatin induces autophagic cell death in EAhy926 human endothelial cells Histol Histopathol 18 IssueID3 715–26 Occurrence Handle12792883

    PubMed  Google Scholar 

  27. I Ding JZ Sun B Fenton et al. (2001) ArticleTitleIntratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas Cancer Res 61 IssueID2 526–31 Occurrence Handle11212245

    PubMed  Google Scholar 

  28. A Ardizzoia P Lissoni F Brivio et al. (1992) ArticleTitleTumor necrosis factor in solid tumors: Increased blood levels in the metastatic disease J Biol Regul Homeost Agents 6 IssueID3 103–7 Occurrence Handle1492596

    PubMed  Google Scholar 

  29. T Matsumoto K Fujimoto-Ouchi S Tamura et al. (1999) ArticleTitleTumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma Br J Cancer 79 IssueID5–6 764–9 Occurrence Handle10.1038/sj.bjc.6690123 Occurrence Handle10070867

    Article  PubMed  Google Scholar 

  30. K Mori K Fujimoto-Ouchi T Ishikawa et al. (1996) ArticleTitleMurine interleukin-12 prevents the development of cancer cachexia in a murine model Int J Cancer 67 IssueID6 849–55 Occurrence Handle10.1002/(SICI)1097-0215(19960917)67:6<849::AID-IJC15>3.0.CO;2-X Occurrence Handle8824558

    Article  PubMed  Google Scholar 

  31. M Hafner P Orosz A Kruger et al. (1996) ArticleTitleTNF promotes metastasis by impairing natural killer cell activity Int J Cancer 66 IssueID3 388–92 Occurrence Handle10.1002/(SICI)1097-0215(19960503)66:3<388::AID-IJC20>3.0.CO;2-6 Occurrence Handle8621262

    Article  PubMed  Google Scholar 

  32. P Orosz A Kruger M Hubbe et al. (1995) ArticleTitlePromotion of experimental liver metastasis by tumor necrosis factor Int J Cancer 60 IssueID6 867–71 Occurrence Handle7896459

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery,Nagoya City University Graduate School of Medical Sciences, University1-Kawasumi, Nagoya, Mizuho-cho, Mizuho-ku, Japan

    Laiyuan Zhao, Takashi Hashimoto, Tatsuya Suzuki & Tadao Manabe

  2. Department of Experimental Pathology and Tumor Biology,Graduate School of Medical Sciences Nagoya City, University1-Kawasumi, Nagoya, Mizuho-cho, Mizuho-ku, Japan

    Mitsuru Futakuchi, Shugo Suzuki, Yoshiaki Ohhara & Tomoyuki Shirai

  3. Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

    Mitsuru Futakuchi

Authors
  1. Laiyuan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuru Futakuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shugo Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshiaki Ohhara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takashi Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tatsuya Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tadao Manabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tomoyuki Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuru Futakuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, L., Futakuchi, M., Suzuki, S. et al. Kinetics of Marked Development of Lung Metastasis of Rat Prostatic Carcinomas Transplanted in Syngeneic Rats. Clin Exp Metastasis 22, 309–318 (2005). https://doi.org/10.1007/s10585-005-0054-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-005-0054-8

Keywords

Search

Navigation